product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Claudin-1 (D5H1D) XP Rabbit mAb
catalog :
13255
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D5H1D
reactivity :
human, mouse, swine
application :
western blot, immunohistochemistry, flow cytometry
more info or order :
Cell Signaling Technology product webpage
citations: 10
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; mouse; 1:100; loading ...; fig 5a
Ellis S, Gomez N, Levorse J, Mertz A, Ge Y, Fuchs E. Distinct modes of cell competition shape mammalian tissue morphogenesis. Nature. 2019;: pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 7j
Caino M, Seo J, Wang Y, Rivadeneira D, Gabrilovich D, Kim E, et al. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest. 2017;127:3755-3769 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 6d
Li X, Liu W, Chen X, Wang Y, Shi D, Zhang H, et al. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer. Int J Mol Med. 2017;39:927-935 pubmed publisher
  • flow cytometry; human; loading ...; fig S3a
Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  • western blot; human; loading ...; fig 10
Boylan K, Buchanan P, Manion R, Shukla D, Braumberger K, Bruggemeyer C, et al. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate. Oncotarget. 2017;8:9717-9738 pubmed publisher
  • immunohistochemistry; mouse; loading ...; fig 4b
Zhang Q, Liu S, Parajuli K, Zhang W, Zhang K, Mo Z, et al. Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene. 2017;36:687-699 pubmed publisher
  • western blot; swine; 1:2000; fig 6A
Springler A, Hessenberger S, Schatzmayr G, Mayer E. Early Activation of MAPK p44/42 Is Partially Involved in DON-Induced Disruption of the Intestinal Barrier Function and Tight Junction Network. Toxins (Basel). 2016;8: pubmed publisher
Frausto R, Chung D, Boere P, Swamy V, Duong H, Kao L, et al. ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing. PLoS ONE. 2019;14:e0218279 pubmed publisher
Sanawar R, Mohan Dan V, Santhoshkumar T, Kumar R, Pillai M. Estrogen receptor-α regulation of microRNA-590 targets FAM171A1-a modifier of breast cancer invasiveness. Oncogenesis. 2019;8:5 pubmed publisher
Boire A, Zou Y, Shieh J, Macalinao D, Pentsova E, Massague J. Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell. 2017;168:1101-1113.e13 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.